GARY BROUILLETTE: Open Payments
NPI 1780044834 · MARSHALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 6 companies in 2025. Trend: 2023 $543 · 2024 $442 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $85 |
| ABBVIE INC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Amgen Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $18 |
| Viatris Specialty LLC | 1 | $14 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, QULIPTA, VRAYLAR, MOUNJARO, BREZTRI, SHINGRIX.
Industry payments across TX — which companies pay providers there.
